COVID-19 Clinical Trials
Clinical trials help researchers develop new and better treatments. The information they provide is the only way for medical breakthroughs to reach the public. During the current COVID-19 pandemic, it’s vital that patients and healthy volunteers participate in research related to the virus and its effects on our physical and mental health.
At this time, we invite to you open a profile through MyChart so that we are able to know your preferred areas of interest so our recruitment team may contact you with trials as they become available.
If you have questions or concerns, please contact us at helpusdiscover@yale.edu or call 1-877-978-8343.
COVID-19 Clinical Trials
- COVID-19 OutpatientTopical Antibacterial Agents for Prevention of COVID-19Principal Investigator: Charles Dela Cruz
- COVID-19 Inpatient, COVID-19 OutpatientLong Covid: Understanding Immune, Symptom, and Treatment Experiences Nationwide (LISTEN Study)Principal Investigator: Harlan Krumholz
- COVID-19 Inpatient, COVID-19 OutpatientPatient response to COVID19 outbreakPrincipal Investigator: Erin Longbrake
- Diseases of the Nervous SystemEvaluating the Immune Response to COVID-19 Vaccination in B-cell Depleted PatientsPrincipal Investigator: Erin Longbrake
- COVID-19 Outpatient, COVID-19 Inpatient, Women's HealthI-SPY COVID TRIAL: An Adaptive Platform Trial to Reduce Mortality and Ventilator Requirements for Critically Ill PatientsPrincipal Investigator: Jon Koff